Regeneron CEO: We’ll Need Covid Antibodies To Work Against Omicron If It Surges
Following is the unofficial transcript of a CNBC interview with Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Co-Founder & CEO Dr. Leonard Schleifer on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Thursday, December 16. Following is a link to video on CNBC.com: Q3 2021 hedge fund letters, conferences and more Regeneron CEO: We’ll Need Covid Antibodies To Work Against Omicron If It SurgesMEG TIRRELL: Becky, thanks so much. Regeneron just a few moments ago saying its antibody drug used to treat patients with COVID loses potency against the Omicron variant. Dr. Len Schleifer is the CEO of Regeneron...